These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26889247)

  • 41. Pemetrexed and bevacizumab-containing chemotherapy for pleomorphic carcinoma of the lung.
    Tamura T; Ohara G; Kagohashi K; Kawaguchi M; Kurishima K; Satoh H
    Mol Clin Oncol; 2016 Apr; 4(4):616-618. PubMed ID: 27073676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale and Design of a Randomized Phase 2 Trial of Gefitinib Plus Bevacizumab vs Gefitinib Alone in Patients with Epidermal Growth Factor Receptor Mutant Non-Squamous Non-Small-Cell Lung Cancer: Study Protocol.
    Kitagawa C; Kada A; Saito AM; Ichinose Y; Saka H
    Kurume Med J; 2019 May; 65(2):77-81. PubMed ID: 30429415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A Patient with Lung Adenocarcinoma, Lymphangitis Carcinomatosa, and Multiple Bone Metastases Who Achieved Long-Term Survival after Successful Treatment with Carboplatin, Paclitaxel, and Bevacizumab].
    Suzuki E; Tanahashi M; Yukiue H; Yoshii N; Shitara M; Fujino T; Niwa H
    Gan To Kagaku Ryoho; 2016 May; 43(5):617-20. PubMed ID: 27210094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis.
    Zhao Y; Liu J; Cai X; Pan Z; Liu J; Yin W; Chen H; Xie Z; Liang H; Wang W; Guo Z; Zhao S; Liang W; He J
    BMJ; 2019 Oct; 367():l5460. PubMed ID: 31591158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer.
    Weiss JM; Villaruz LC; O'Brien J; Ivanova A; Lee C; Olson JG; Pollack G; Gorman R; Socinski MA; Stinchombe TE
    Clin Lung Cancer; 2016 Mar; 17(2):128-32. PubMed ID: 26774201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.
    Kozuki T; Nogami N; Kitajima H; Iwasawa S; Sakaida E; Takiguchi Y; Ikeda S; Yoshida M; Kato T; Miyamoto S; Sakamaki K; Shinkai T; Watanabe K
    BMC Cancer; 2016 May; 16():306. PubMed ID: 27177035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late-stage metastasis to the choroid from follicular thyroid carcinoma--case report.
    Seneviratne DR; Stavrou P; Good P
    Optometry; 2011 Apr; 82(4):215-7. PubMed ID: 21439488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.
    Ichihara E; Hotta K; Nogami N; Kuyama S; Kishino D; Fujii M; Kozuki T; Tabata M; Harada D; Chikamori K; Aoe K; Ueoka H; Hosokawa S; Bessho A; Hisamoto-Sato A; Kubo T; Oze I; Takigawa N; Tanimoto M; Kiura K
    J Thorac Oncol; 2015 Mar; 10(3):486-91. PubMed ID: 25695221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116.
    Casey EM; Harb W; Bradford D; Bufill J; Nattam S; Patel J; Fisher W; Latz JE; Li X; Wu J; Hanna N
    J Thorac Oncol; 2010 Nov; 5(11):1815-20. PubMed ID: 20881647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complete remission of gestational choriocarcinoma with choroidal metastasis treated with systemic chemotherapy alone: case report and review of literature.
    Ino K; Mitsui T; Nomura S; Kikkawa F; Mizutani S
    Gynecol Oncol; 2001 Dec; 83(3):601-4. PubMed ID: 11733980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful pemetrexed-containing chemotherapy for epidermal growth factor receptor mutation-positive adenosquamous cell carcinoma of the lung: A case report.
    Watanabe H; Tamura T; Kagohashi K; Kawaguchi M; Kurishima K; Satoh H
    Mol Clin Oncol; 2016 Apr; 4(4):628-630. PubMed ID: 27073680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.
    Uchibori K; Satouchi M; Sueoka-Aragane N; Urata Y; Sato A; Imamura F; Inoue T; Tachihara M; Kobayashi K; Katakami N; Kokan C; Hirashima T; Iwanaga K; Mori M; Aoe K; Morita S; Negoro S
    Lung Cancer; 2018 Oct; 124():65-70. PubMed ID: 30268482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Metastatic neoplasia in the optic nerve].
    Mili Boussen I; Kamoun R; Boussen H; Dhiab T; Rahal K; Hamzaoui A; Ouertani A
    Rev Neurol (Paris); 2004 Nov; 160(11):1071-4. PubMed ID: 15602349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.
    Bagley SJ; Talento S; Mitra N; Meropol NJ; Cohen RB; Langer CJ; Vachani A
    J Natl Compr Canc Netw; 2019 May; 17(5):469-477. PubMed ID: 31085759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.
    Gautschi O; Mach N; Rothschild SI; Li Q; Stahel RA; Zippelius A; Cathomas R; Früh M; Betticher DC; Peters S; Rauch D; Feilchenfeldt J; Bubendorf L; Savic S; Jaggi R; Leibundgut EO; Largiadèr C; Brutsche M; Pilop C; Stalder L; Pless M; Ochsenbein AF;
    Clin Lung Cancer; 2015 Sep; 16(5):358-65. PubMed ID: 25843489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy.
    Yang CJ; Hung JY; Tsai MJ; Wu KL; Liu TC; Chou SH; Lee JY; Hsu JS; Huang MS; Chong IW
    BMC Pharmacol Toxicol; 2017 May; 18(1):21. PubMed ID: 28486985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.
    Cardona AF; Rojas L; Wills B; Arrieta O; Carranza H; Vargas C; Otero J; Cuello M; Corrales L; Martín C; Ortiz C; Franco S; Rosell R;
    PLoS One; 2016; 11(5):e0154293. PubMed ID: 27191954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Choroidal metastasis as a presenting manifestation of a lung adenocarcinoma with response to afatinib.
    Contreras-Díaz M; Medina-Tapia A; Martínez-Bernal G; Rueda-Rueda T; López-Herrero F; Molina-Socola FE; Sánchez-Vicente JL
    Arch Soc Esp Oftalmol; 2016 Nov; 91(11):551-555. PubMed ID: 27046001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Choroid metastases revealing pulmonary adenocarcioma resolved with chemotherapy].
    Battikh MH; Ben Yahia S; Ben Sayah MM; Maatallah A; Joobeur S; Rouatbi N; Khairallah M; El Kamel A
    Rev Pneumol Clin; 2004 Dec; 60(6 Pt 1):353-6. PubMed ID: 15699909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.